HRT Financial’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-37,447
Closed -$1.05M 2504
2024
Q1
$1.05M Sell
37,447
-9,097
-20% -$263K 0.01% 861
2023
Q4
$1.64M Sell
46,544
-1,733
-4% -$53.3K 0.01% 745
2023
Q3
$1.49M Sell
48,277
-164,548
-77% -$4.67M 0.01% 765
2023
Q2
$5.33M Buy
212,825
+200,270
+1,595% +$5.8M 0.05% 267
2023
Q1
$463K Buy
+12,555
New +$550K 0.01% 1440
2022
Q3
Sell
-46,518
Closed -$2.32M 3049
2022
Q2
$2.32M Buy
46,518
+34,191
+277% +$2.05M 0.03% 507
2022
Q1
$784K Buy
+12,327
New +$802K 0.01% 1223
2021
Q4
Sell
-11,689
Closed -$674K 3492
2021
Q3
$674K Buy
+11,689
New +$695K ﹤0.01% 1731
2021
Q1
Sell
-10,765
Closed -$323K 2842
2020
Q4
$323K Buy
10,765
+105
+1% +$2.68K 0.01% 1243
2020
Q3
$229K Buy
+10,660
New +$209K 0.01% 1286
2020
Q1
Sell
-4,758
Closed -$228K 958
2019
Q4
$228K Buy
+4,758
New +$197K 0.01% 882

Other funds holding GCO

HRT Financial's GCO Position: Q2 2024 in Review

HRT Financial sold out of Genesco (GCO) in Q2 2024, closing a stake of 37,447 shares — an estimated $1.05M sold.

HRT Financial first reported a position in GCO in Q4 2019 and held it in 11 quarters. The position peaked at $5.33M in Q2 2023. 114 funds tracked by Wall St. Rank hold GCO as of Q2 2024.

  • HRT Financial reported no remaining Genesco position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 37,447 Genesco shares in Q2 2024, an estimated $1.05M.
  • HRT Financial first reported a position in Genesco in Q4 2019 and held it in 11 quarters.
  • HRT Financial's Genesco position peaked at $5.33M in Q2 2023.
  • 114 funds tracked by Wall St. Rank held Genesco as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.